Is Nubeqa (darolutamide) covered by Medicare?
Nubeqa is a prescription drug for prostate cancer, and Medicare coverage typically depends on which part you’re using and whether your plan has the drug on its formulary. Medicare generally doesn’t “cover” a medication automatically; instead, coverage comes through:
- Original Medicare (Part D) for prescription drugs. Your Part D plan decides whether Nubeqa is covered and what your cost will be (often tied to tier placement and any prior authorization or step therapy rules).
- Medicare Advantage (Part C) plans. These plans usually include Part D drug coverage, and coverage for Nubeqa is still determined by the plan’s formulary rules.
Because formularies vary by plan and location, the only reliable way to confirm for your situation is to check your specific Part D/Advantage formulary or ask your plan whether Nubeqa (darolutamide) is covered and under what requirements.
How can you check if your Medicare plan covers Nubeqa?
A good workflow is:
- Look up Nubeqa in your plan’s online drug list (formulary) and note the drug tier.
- Check whether the plan requires prior authorization, step therapy, or quantity limits for Nubeqa.
- Review the expected copay/coinsurance if it’s covered under your tier.
If you tell me your plan type (Original Medicare + Part D vs. Medicare Advantage) and the plan name (or your ZIP code), I can help you identify the most direct place to check and what terms to look for.
What if Nubeqa isn’t on your plan’s formulary?
If your plan doesn’t cover Nubeqa or covers it only with strict conditions, you can usually request:
- A formulary exception (a coverage override), or
- Prior authorization approval if the plan requires it.
Coverage decisions and appeal rights are part of Medicare Part D/Medicare Advantage rules, but the exact process and documentation requirements depend on the plan.
Does Medicare cover Nubeqa under Parts A or B?
Nubeqa is an oral cancer medicine, and oral oncology drugs are generally handled under Part D (or included in Medicare Advantage Part C drug benefits), not under Part A (hospital) or Part B (medical services). If your situation involves an infusion or administration that could be billed under Part B (less likely for Nubeqa itself), coverage would be different—but for Nubeqa specifically, you should assume Part D/Advantage.
What do other patients usually run into (cost and paperwork)?
Common friction points with Medicare drug coverage for cancer medicines include:
- Higher cost-sharing based on formulary tier
- Prior authorization requirements
- The need for documentation from the prescriber
Your prescriber’s office often helps with prior authorizations once you confirm the plan rules.
Sources
I don’t have access to your specific Medicare plan’s formulary here, and you didn’t provide your plan name or ZIP code. If you share that, I can help you narrow down the exact coverage pathway (Part D vs. Advantage) and what to check.